Revolutionize Cancer Diagnosis - CellBio Technology 
| Number of wells | 96 |
| Principle | Direct Sandwich |
| Assay format | Semi-Quantitative |
| Total incubation time | 105 minutes |
| Sample type | Serum or Plasma |
| Sample volume | 10 μL |
| Reading wavelength | 450nm |
| Storage | 2-8°C |
| Certification | Taiwan EUA 1100000263 / CE |
5 serum samples collected from RT-PCR confirmed COVID-19 patients were tested. 139 normal healthy patients with samples collected before COVID-19 outbreak were tested. The results are as follows：
| PERFORMANCE | Test Positive | Test Negative |
| Confirmed Positive | 5 | 0 |
| Confirmed Negative | 0 | 139 |
| Inter-assay precision CV | < 10% | Inter-assay precision CV | < 20% |
The diagnostic sensitivity is 100%；The diagnostic specificity is 100%
| Negative (n=89) | Positive (n=5) | ||||||
| Company A | Company A | ||||||
| Pos | Neg | total | Pos | Neg | total | ||
| GBC | Pos | 0 | 0 | 0 | 4 | 1 | 5 |
| Neg | 2 | 87 | 89 | 0 | 0 | 0 | |
| total | 2 | 87 | 89 | 4 | 1 | 5 | |
| Sensitivity | GBC | 100% | |||||
| Company A | 80% | ||||||
| Specificity | GBC | 100% | |||||
| Company A | 97.7% | ||||||
| Catalogue No. | Product |
| 4ECO001 | GB SARS-COV-2 Ab ELISA - 96T |
| 4ECO002 | GB SARS-COV-2 Ab ELISA - 480T |
